COYA · Coya Therapeutics, Inc. · Documents
Market Cap
$98.76M
Shares
23.46M
Volume · Oct 20
82.91K
Avg daily vol (3M)
137.74K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2024-07-15 | 2024-07-12 | |
| S-3 | — | 2024-06-14 | — | |
| 8-K | — | 2024-06-05 | 2024-06-04 | |
| 8-K | — | 2024-05-20 | 2024-05-17 | |
| 8-K | — | 2024-05-09 | — | |
| 10-Q | — | 2024-05-09 | 2024-03-31 | |
| 8-K | — | 2024-05-08 | — | |
| DEFA14A | — | 2024-03-29 | — | |
| DEFA14A | — | 2024-03-28 | — | |
| DEF 14A | — | 2024-03-28 | 2024-05-08 | |
| ARS | — | 2024-03-28 | 2023-12-31 | |
| 8-K | — | 2024-03-19 | — | |
| 10-K | — | 2024-03-19 | 2023-12-31 | |
| 8-K | — | 2024-01-19 | — | |
| S-3 | — | 2024-01-04 | — | |
| 8-K | — | 2023-12-20 | 2023-12-19 | |
| 8-K | — | 2023-12-06 | 2023-12-05 | |
| 10-Q | — | 2023-11-08 | 2023-09-30 | |
| 8-K | — | 2023-11-08 | — | |
| 8-K | — | 2023-08-21 | 2023-08-18 | |
| 10-Q | — | 2023-08-08 | 2023-06-30 | |
| 8-K | — | 2023-08-08 | — | |
| 8-K | — | 2023-07-14 | 2023-07-11 | |
| 8-K | — | 2023-07-10 | 2023-07-03 | |
| 8-K | — | 2023-06-29 | 2023-06-28 | |
| 8-K | — | 2023-06-12 | — | |
| 8-K | — | 2023-05-23 | 2023-05-22 | |
| DEFA14A | — | 2023-05-19 | — | |
| DEF 14A | — | 2023-05-19 | 2023-06-28 | |
| ARS | — | 2023-05-19 | 2022-12-31 | |
| 8-K | — | 2023-05-16 | — | |
| 8-K | — | 2023-05-10 | — | |
| 10-Q | — | 2023-05-10 | 2023-03-31 | |
| 10-K/A | — | 2023-05-01 | 2022-12-31 | |
| 10-K | — | 2023-03-29 | 2022-12-31 | |
| 8-K | — | 2023-03-29 | — | |
| 8-K | — | 2023-03-22 | 2023-03-16 | |
| 8-K | — | 2023-03-21 | — | |
| 8-K | — | 2023-03-13 | — | |
| 8-K | — | 2023-03-01 | 2023-02-27 | |
| 8-K | — | 2023-01-25 | — | |
| S-1/A | — | 2022-12-13 | — | |
| S-1/A | — | 2022-12-05 | — | |
| S-1 | — | 2022-11-18 | — |
Showing 51–94 of 94 filings